IMU-838, a Developmental DHODH inhibitor in phase II for autoimmune disease, shows anti-SARS-CoV-2 and broad-spectrum antiviral efficacy in vitro
Moreover, in zeaxanthin-treated melanoma cells DNA internucleosomal fragmentation leading to cell cycle arrest and apoptosis were observed 187 , without impairing the cell viability of non-cancer melanocytes 193 , in relation to which the mentioned carotenoids have a photoprotective effect 194
Research suggests it encourages the breakdown of stored fat without significantly affecting blood sugar or acting through the IGF-1 pathway
That makes the combination easy to understand clinically, even while the final product remains investigational
Common adverse effects are predominantly gastrointestinal and typically emerge during dose escalation: Nausea (affecting 2050% of users initially) Vomiting and diarrhoea Constipation Abdominal pain and bloating Reduced appetite (therapeutic effect but may be excessive) Fatigue and headache Injection site reactions (redness, swelling or itching) These effects usually diminish over several weeks as the body adjusts
Now I want to hear from you: Do you know if you are B12 deficient
